Q9Y5B9 (SP16H_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 103.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: FACT complex subunit SPT16 Alternative name(s): Chromatin-specific transcription elongation factor 140 kDa subunit FACT 140 kDa subunit FACTp140 Facilitates chromatin transcription complex subunit SPT16 Short name=hSPT16 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1047 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Also involved in vitamin D-coupled transcription regulation via its association with the WINAC complex, a chromatin-remodeling complex recruited by vitamin D receptor (VDR), which is required for the ligand-bound VDR-mediated transrepression of the CYP27B1 gene By similarity. Ref.6 Ref.7 Ref.8 Ref.9 Ref.11 Ref.12 Ref.14 |
| Subunit structure | Component of the FACT complex, a stable heterodimer of SSRP1 and SUPT16H. Also component of a CK2-SPT16-SSRP1 complex which forms following UV irradiation, composed of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B. Component of the WINAC complex, at least composed of SMARCA2, SMARCA4, SMARCB1, SMARCC1, SMARCC2, SMARCD1, SMARCE1, ACTL6A, BAZ1B/WSTF, ARID1A, SUPT16H, CHAF1A and TOP2B. Interacts with NEK9. Binds to histone H2A-H2B. Interacts with GTF2E2. Ref.1 Ref.5 Ref.9 Ref.10 Ref.11 Ref.13 |
| Subcellular location | Nucleus. Chromosome. Note: Colocalizes with RNA polymerase II on chromatin. Recruited to actively transcribed loci. Ref.1 |
| Tissue specificity | Ubiquitous. Ref.5 |
| Domain | The Glu-rich acidic region in C-terminus is essential for FACT activity. Ref.12 |
| Post-translational modification | ADP-ribosylated. ADP-ribosylation by PARP1 is induced by genotoxic stress and correlates with dissociation of FACT from chromatin. |
| Sequence similarities | Belongs to the peptidase M24 family. SPT16 subfamily. |
| Caution | Although related to the peptidase M24 family, this protein lacks conserved active site residues suggesting that it may lack peptidase activity. |
| Sequence caution | The sequence AAH64561.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence AAH73849.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.3 Ref.4 | ||||||
| Chain | 2 – 1047 | 1046 | FACT complex subunit SPT16 | PRO_0000245169 | |||||
Regions | |||||||||
| Coiled coil | 432 – 507 | 76 | Potential | ||||||
| Compositional bias | 926 – 1011 | 86 | Glu-rich (acidic) | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.3 Ref.4 | ||||||
| Modified residue | 139 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 188 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 196 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 223 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 508 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 513 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 650 | 1 | Phosphoserine Ref.19 Ref.21 | ||||||
| Modified residue | 658 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 732 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 786 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 903 | 1 | Phosphothreonine Ref.19 | ||||||
| Modified residue | 904 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 979 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 982 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 986 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 1015 | 1 | Phosphoserine Ref.17 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins." Orphanides G., Wu W.-H., Lane W.S., Hampsey M., Reinberg D. Nature 400:284-288(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, INTERACTION WITH SSRP1; H2A AND H2B. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-638. Tissue: Brain, Eye and Testis. |
| [3] | Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W. Submitted (JUL-2007) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-12 AND 480-490, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, MASS SPECTROMETRY. Tissue: Hepatoma. |
| [4] | Bienvenut W.V., Vousden K.H., Lukashchuk N. Submitted (MAR-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-12; 93-108 AND 582-596, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, MASS SPECTROMETRY. Tissue: Lung carcinoma. |
| [5] | "Functional interaction of general transcription initiation factor TFIIE with general chromatin factor SPT16/CDC68." Kang S.-W., Kuzuhara T., Horikoshi M. Genes Cells 5:251-263(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 801-1047, TISSUE SPECIFICITY, INTERACTION WITH GTF2E2. |
| [6] | "FACT, a factor that facilitates transcript elongation through nucleosomes." Orphanides G., LeRoy G., Chang C.-H., Luse D.S., Reinberg D. Cell 92:105-116(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "Requirement of RSF and FACT for transcription of chromatin templates in vitro." LeRoy G., Orphanides G., Lane W.S., Reinberg D. Science 282:1900-1904(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [8] | "FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH." Wada T., Orphanides G., Hasegawa J., Kim D.-K., Shima D., Yamaguchi Y., Fukuda A., Hisatake K., Oh S., Reinberg D., Handa H. Mol. Cell 5:1067-1072(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [9] | "A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1." Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H., Goodman R., Lozano G., Zhao Y., Lu H. Mol. Cell 7:283-292(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SSRP1; CSNK2A1; CSNK2A2 AND CSNK2B. |
| [10] | "p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex." Keller D.M., Lu H. J. Biol. Chem. 277:50206-50213(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SSRP1; CSNK2A1; CSNK2A2 AND CSNK2B. |
| [11] | "The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome." Kitagawa H., Fujiki R., Yoshimura K., Mezaki Y., Uematsu Y., Matsui D., Ogawa S., Unno K., Okubo M., Tokita A., Nakagawa T., Ito T., Ishimi Y., Nagasawa H., Matsumoto T., Yanagisawa J., Kato S. Cell 113:905-917(2003) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE WINAC COMPLEX, FUNCTION. |
| [12] | "FACT facilitates transcription-dependent nucleosome alteration." Belotserkovskaya R., Oh S., Bondarenko V.A., Orphanides G., Studitsky V.M., Reinberg D. Science 301:1090-1093(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DOMAIN. |
| [13] | "Nek9, a novel FACT-associated protein, modulates interphase progression." Tan B.C.-M., Lee S.-C. J. Biol. Chem. 279:9321-9330(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NEK9. |
| [14] | "Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II." Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D. Cell 125:703-717(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [15] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-979 AND SER-982, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Modulation of nucleosome-binding activity of FACT by poly(ADP-ribosyl)ation." Huang J.-Y., Chen W.-H., Chang Y.-L., Wang H.-T., Chuang W.-T., Lee S.-C. Nucleic Acids Res. 34:2398-2407(2006) [PubMed] [Europe PMC] [Abstract] Cited for: ADP-RIBOSYLATION. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-508 AND SER-1015, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-139; LYS-196; LYS-223; LYS-513; LYS-732; LYS-786 AND LYS-904, MASS SPECTROMETRY. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-650; THR-903; SER-979 AND SER-982, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188; SER-650; SER-658; SER-979; SER-982 AND SER-986, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF152961 mRNA. Translation: AAD43978.1. BC000565 mRNA. Translation: AAH00565.1. BC014046 mRNA. Translation: AAH14046.1. BC064561 mRNA. Translation: AAH64561.1. Sequence problems. BC073849 mRNA. Translation: AAH73849.1. Sequence problems. AF164924 mRNA. Translation: AAF28231.1. |
| IPI | IPI00026970. |
| RefSeq | NP_009123.1. NM_007192.3. |
| UniGene | Hs.213724. |
3D structure databases | |
| ProteinModelPortal | Q9Y5B9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-42757N. |
| IntAct | Q9Y5B9. 13 interactions. |
| MINT | MINT-2823866. |
| STRING | 9606.ENSP00000216297. |
Protein family/group databases | |
| MEROPS | M24.974. |
PTM databases | |
| PhosphoSite | Q9Y5B9. |
Polymorphism databases | |
| DMDM | 74753511. |
Proteomic databases | |
| PaxDb | Q9Y5B9. |
| PeptideAtlas | Q9Y5B9. |
| PRIDE | Q9Y5B9. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000216297; ENSP00000216297; ENSG00000092201. |
| GeneID | 11198. |
| KEGG | hsa:11198. |
| UCSC | uc001wao.2. human. |
Organism-specific databases | |
| CTD | 11198. |
| GeneCards | GC14M021819. |
| HGNC | HGNC:11465. SUPT16H. |
| HPA | CAB022551. |
| MIM | 605012. gene. |
| neXtProt | NX_Q9Y5B9. |
| PharmGKB | PA36251. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG5406. |
| HOGENOM | HOG000209079. |
| HOVERGEN | HBG092544. |
| InParanoid | Q9Y5B9. |
| OMA | MEIIDAD. |
| OrthoDB | EOG40K7Z3. |
| PhylomeDB | Q9Y5B9. |
Enzyme and pathway databases | |
| Reactome | REACT_116125. Disease. REACT_1788. Transcription. REACT_1892. Elongation arrest and recovery. REACT_71. Gene Expression. |
Gene expression databases | |
| ArrayExpress | Q9Y5B9. |
| Bgee | Q9Y5B9. |
| CleanEx | HS_SUPT16H. |
| Genevestigator | Q9Y5B9. |
| GermOnline | ENSG00000092201. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.90.230.10. 1 hit. |
| InterPro | IPR013719. DUF1747. IPR013953. FACT_Spt16p. IPR000994. Pept_M24_structural-domain. [Graphical view] |
| Pfam | PF00557. Peptidase_M24. 1 hit. PF08512. Rtt106. 1 hit. PF08644. SPT16. 1 hit. [Graphical view] |
| SUPFAM | SSF55920. Peptidase_M24_cat_core. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | SUPT16H. human. |
| GenomeRNAi | 11198. |
| NextBio | 42621. |
| SOURCE | Search... |
Entry information
| Entry name | SP16H_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y5B9 Secondary accession number(s): Q6GMT8 Q9NRX0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 14 Human chromosome 14: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
